David Perry (entrepreneur)


David Perry is the CEO and Director of Indigo Agriculture, an agricultural technology company headquartered in Boston, United States. He is a serial entrepreneur in the life sciences industry. He has co-founded Anacor Pharmaceuticals, Chemdex, NexPrise, Virogen and FareWell. He is known to lead successful IPOs while generating returns for investors.

Early life and education

Perry was raised on his family's farm in rural Arkansas. He holds a BS from the University of Tulsa and an MBA from Harvard Business School. He also attended the United States Air Force Academy. He began his career at Exxon, where he managed the operations and maintenance of an oil refinery.

Career

In 1995, while at Harvard Business School, David Perry founded Virogen, a biotechnology company focused on diagnostics.
While at Virogen, he felt that scientists spent a lot of time in procuring life sciences products through conventional catalog ordering. So in 1997, he founded Chemdex, headquartered in California. It is a B2B marketplace focusing on the life-sciences industry and sells laboratory chemicals and other scientific equipments online. In the same year, he also created the parent company of Chemdex, called Ventro Corporation which was later sold to Nexprise. He served as its CEO and President until November 2001.
In 2002, Perry co-founded Anacor Pharmaceuticals and served as its CEO for twelve years. The biopharmaceutical company is focused on developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. In 2016, the company was acquired by Pfizer for $5.4 billion.
In 2015, Perry co-founded Better Therapeutics, a digital therapeutics company focused on preventing and reversing chronic disease through lifestyle changes. He is also on the Board of Directors of the human microbiome company, Evelo Biosciences.
In late 2015, Perry began his current role as President, Director and CEO of Indigo Agriculture.

Awards and recognitions